Skip to main content
. 2022 Jul 14;140(2):140–151. doi: 10.1182/blood.2021014708

Figure 4.

Figure 4.

Analysis of plasma antithrombin in 2 symptomatic unrelated Norwegian probands carrying the p.Asn224His mutation in the heterozygous state and 2 healthy control samples. (A) Crossed immunoelectrophoresis in the presence of heparin. (B) Western blot of native PAGE and SDS-PAGE. The aberrant forms of antithrombin detected in the probands are pointed by red arrows. The anti-FXa activity of the sample evaluated by Western blot is also indicated.